Article
A LC-MS/MS method to quantify the novel cholesterol lowering drug ezetimibe in human serum, urine and feces in healthy subjects genotyped for SLCO1B1.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences - 2 Jan 2006
Oswald Stefan, Scheuch Eberhard, Cascorbi Ingolf, Siegmund Werner
Abstract excerpt
Ezetimibe (Ezetrol) is a novel cholesterol lowering drug which disposition is not fully understood in man. We developed a selective and high-sensitive assay to measure serum concentration-time profiles, renal and fecal elimination of ezetimibe in pharmacokinetic studies. Ezetimibe glucuronide, the major metabolite of ezetimibe was determined by enzymatic degradation to the parent compound. Ezetimibe was measured...
Topics
Join the communities discussing this publication.
